ROC-PCAProstate Cancer Unit

Prostate cancer (PCa) is a very common pathology which affects up to 25% of men over 50 years old and 80% of those over 80.

The cause is unknown, but there is likely a relationship with hormones, age, race, and it has a clear genetic component since, if a first-degree relative (parent or siblings) has it, the risk of suffering from it increases.

At ROC Urología we have a multidisciplinary team dedicated to PCa comprising professionals with extensive experience and prestige in this field.

Our team consists not only of urologists, but of uro-pathologists, uro-radiologists, oncologists and radiotherapists, all focused on the diagnosis and treatment of PCa.

We also work in a centre equipped with the highest level technology, to be able to diagnose and stratify the disease and design a personalised treatment:

• Multiparametric magnetic resonance.
• Fusion biopsy.
• Helical CT with “3D” reconstruction
• Skeletal scintigraphy./b>
• Positron Emission Tomography (PET/PET-CT/Choline PET).
• Biochemical and molecular tumour markers of PCa.